Complete Up To Date Information about Buscopan™ Injectable Solution.
NADA Number: 141-228 | |
| Proprietary Name |
Buscopan™ Injectable Solution |
|---|---|
| Sponsor |
Boehringer Ingelheim Vetmedica, Inc. |
| Sponsor Address |
2621 North Belt Highway St.Joseph, MO 64502 USA |
| Ingredients |
N-Butylscopolammonium bromide |
| Species |
Horse, no use class stated or implied |
| Routes of Administration |
Intravenous |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Exclusivity |
No product using N-butylscopolammonium as an active ingredient has been previously approved for use in horses in any other application. |
|
Dosage Amount, Indications & Limitations |
522.275 N-Butylscopolammonium bromide. Specifications. Each milliliter of solution contains 20 milligrams (mg) N-butylscopolammonium bromide. Conditions of use Horses Amount: 0.3 mg per kilogram of body weight (0.14 mg per pound) slowly intravenously Indications: For the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic, and simple impactions. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. |